The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND This systematic review and meta-analysis aimed to update and give an overview of the evidence from published literature that focused on the efficacy of cognitive behaviour therapy (CBT) in the management of somatoform disorders and medically unexplained physical symptoms (MUPS). METHODS A comprehensive literature search was carried out through an electronic search of various databases on randomized controlled trials (RCTs). Primary outcome was the severity of somatic symptoms. Secondary outcomes were also measured based on severity of anxiety symptoms, severity of depressive symptoms, social functioning, physical functioning, doctor visits and the compliance with CBT, as well as follow-up visits. Effects were summarized by a random effects model using mean differences or odds ratio with 95% confidence intervals (CIs). RESULTS A total of 15 RCTs comprising 1671 patients with somatoform disorders or MUPS were enrolled in our systematic review and meta-analysis. The main analysis revealed that CBT could alleviate somatic symptoms: -1.31 (95% CI: -2.23 to -0.39, p = 0.005); anxiety symptoms: -1.89 (95% CI: -2.91 to -0.86; p < 0.001); depressive symptoms: -1.93 (95% CI: -3.56 to -0.31; p = 0.020); improve physical functioning: 4.19 (95% CI: 1.90 to 6.49; p < 0.001). The efficacy of CBT on alleviating somatic symptoms, anxiety and depressive symptoms were sustained on follow-up. CBT may not be effective in reducing the number of doctor visits: -1.23 (95% CI: -2.97 to 0.51; p = 0.166); and improving social functioning: 3.27 (95% CI: -0.08 to 6.63; p = 0.056). The results of subgroup analysis indicated that CBT was particularly beneficial when the duration of session was more than 50 min to reduce the severity of somatic symptoms from pre to post treatment time, when it was group based and applied affective and developed good interpersonal strategy during the treatment. Longer duration and frequency such as more than 10 sessions and 12 weeks treatments had significant effect on reduction of the comorbid symptoms including depression and anxiety, but they may underpin low level of compliance of CBT based treatments. CONCLUSIONS CBT is effective for the treatment of somatoform disorders and MUPS by reducing physical symptoms, psychological distress and disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9476-1 · Cited by 3,445
Cognitive therapy: Current status and future directions
Beck, A. T., & Dozois, D. J. A. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-052209-100032 · Cited by 560
Interpersonal Psychotherapy for Depression: A Meta-Analysis
Cuijpers, P., Geraedts, A. S., van Oppen, P., Andersson, G., Markowitz, J. C., & van Straten, A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10101411 · Cited by 511
Deary, V., Chalder, T., & Sharpe, M. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.07.002 · Cited by 480
Kroenke, K., & Swindle, R. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012395 · Cited by 478
Efficacy of treatment for somatoform disorders: a review of randomized controlled trials
Kroenke, K. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31815b00c4 · Cited by 450
The Science of Cognitive Therapy
Hofmann, S. G., Asmundson, G. J. G., & Beck, A. T. (2013) · Behavior Therapy · doi:10.1016/j.beth.2009.01.007 · Cited by 366
Speckens, A. E. M., van Hemert, A. M., Spinhoven, P., Hawton, K. E., Bolk, J. H., & Rooijmans, H. G. M. (1995) · BMJ · doi:10.1136/bmj.311.7016.1328 · Cited by 330
The Relationship Between Homework Compliance and Therapy Outcomes: An Updated Meta-Analysis
Mausbach, B. T., Moore, R., Roesch, S., Cardenas, V., & Patterson, T. L. (2010) · Cognitive Therapy and Research · doi:10.1007/s10608-010-9297-z · Cited by 309
Cited by
Axelsson, E., & Hedman-Lagerlöf, E. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1703182 · Cited by 96
Yang, X., Li, Z., & Sun, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00711 · Cited by 95
Self-citationMatsumoto, K., Hamatani, S., & Shimizu, E. (2021) · Journal of Medical Internet Research · doi:10.2196/31293 · Cited by 67
“Evidence suggests that CBT is effective not only for psychiatric disorders [8] but also for somatic disorders [9].”
BackgroundResultLi, Y., Storch, E. A., Ferguson, S., Li, L., Buys, N., & Sun, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109965 · Cited by 47
Self-citationSarter, L., Heider, J., Witthöft, M., Rief, W., & Kleinstäuber, M. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.03.001 · Cited by 17
Barends, H., Dekker, J., van Dessel, N. C., Twisk, J. W. R., van der Horst, H. E., & van der Wouden, J. C. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111343 · Cited by 10
Selinheimo, S., Vuokko, A., Hublin, C., Järnefelt, H., Karvala, K., Sainio, M., Suojalehto, H., & Paunio, T. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.109962 · Cited by 9
Metadata
- Authors
- Liu, J., Gill, N. S., Teodorczuk, A., Li, Z.-J., & Sun, J.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 245
- Pages
- 98-112
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2896490330
- Cited by
- 145
- References
- 29
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.